Despite much of the past 2 years being engulfed by the devastating consequences of the SAR-CoV-2 pandemic, significant progress, even breathtaking, occurred in the field of chronic myeloid malignancies. Some of this was show-cased at the 15th Post-American Society of Hematology (ASH) and the 25th John Goldman workshops on myeloproliferative neoplasms (MPN) held on 9th-10th December 2020 and 7th-10th October 2021, respectively. The inaugural Post-ASH MPN workshop was set out in 2006 by John Goldman (deceased) and Tariq Mughal to answer emerging translational hematology and therapeutics of patients with these malignancies. Rather than present a resume of the discussions, this perspective focuses on some of the pivotal translational hematology and therapeutic insights in these diseases.
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies / Mughal T.I.; Pemmaraju N.; Bejar R.; Gale R.P.; Bose P.; Kiladjian J.-J.; Prchal J.; Royston D.; Pollyea D.; Valent P.; Brummendorf T.H.; Skorski T.; Patnaik M.; Santini V.; Fenaux P.; Kucine N.; Verstovsek S.; Mesa R.; Barbui T.; Saglio G.; Van Etten R.A.. - In: HEMATOLOGICAL ONCOLOGY. - ISSN 0278-0232. - ELETTRONICO. - (2022), pp. 0-0. [10.1002/hon.2987]
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies
Santini V.;
2022
Abstract
Despite much of the past 2 years being engulfed by the devastating consequences of the SAR-CoV-2 pandemic, significant progress, even breathtaking, occurred in the field of chronic myeloid malignancies. Some of this was show-cased at the 15th Post-American Society of Hematology (ASH) and the 25th John Goldman workshops on myeloproliferative neoplasms (MPN) held on 9th-10th December 2020 and 7th-10th October 2021, respectively. The inaugural Post-ASH MPN workshop was set out in 2006 by John Goldman (deceased) and Tariq Mughal to answer emerging translational hematology and therapeutics of patients with these malignancies. Rather than present a resume of the discussions, this perspective focuses on some of the pivotal translational hematology and therapeutic insights in these diseases.File | Dimensione | Formato | |
---|---|---|---|
Hematological Oncology - 2022 - Mughal - Perspective Pivotal translational hematology and therapeutic insights in chronic.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.09 MB
Formato
Adobe PDF
|
1.09 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.